Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Statements of Cash Flows

v3.21.2
Unaudited Condensed Statements of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net loss $ (10,341) $ (32,176,518)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Change in fair value of warrant liability (10,934,420) 30,806,877
Issuance costs related to warrant liability 0 1,075,021
Change in operating assets and liabilities:    
(Increase)/decrease in dividend receivable 125 (3,758)
(Increase)/decrease in prepaid expenses 274,170 (716,748)
Increase in deferred tax assets (653,071) (78,317)
Increase in accounts payable 9,545,154 248,528
Increase in income tax payable 1 57
Net cash used for operating activities (1,778,382) (844,858)
Cash flows from financing activities:    
Proceeds from sale of Class A common stock to public 0 750,000,000
Proceeds from sale of Private Placement Warrants 0 17,000,000
Payment of underwriting discounts 0 (15,000,000)
Payment of offering costs (375,000) (485,245)
Proceeds from promissory note 0 300,000
Repayment of promissory note 0 (300,000)
Proceeds from working capital note 2,000,000 0
Net cash provided by financing activities 1,625,000 751,514,755
Increase/(decrease) in cash and restricted cash (153,382) 750,669,897
Cash and restricted cash and cash equivalents at beginning of period 750,446,404 5,000
Cash and restricted cash and cash equivalents at end of period 750,293,022 750,674,897
Supplemental disclosure of non-cash financing activities    
Accrued offering costs 0 503,000
Deferred underwriting discount $ 0 $ 26,250,000